Efficacy and safety of canagliflozin compared to sitagliptin and glimepride as add-on therapy in T2DM

field_of_study

Blank

university

Israa University

authors

Bataineh Y.A.; Al-Khames Aga Q.A.; Kurji H.A.; Hasan M.K.; Al-Jaidi B.A.; Al-Shorman H.M.; Faisal R.R.

authors_full_names

Bataineh, Yazan A. (57212404908); Al-Khames Aga, Qutaiba Ahmed (57218582598); Kurji, Hayder Abdulhafedh (57212404236); Hasan, Mohammed Khudair (57212408883); Al-Jaidi, Bilal Ali (26634753400); Al-Shorman, Hashem Mahmoud (57212410740); Faisal, Rafeef Raad (57212408113)

authors_id

57212404908; 57218582598; 57212404236; 57212408883; 26634753400; 57212410740; 57212408113

year

2019

source_title

Journal of Global Pharma Technology

article_title

Efficacy and safety of canagliflozin compared to sitagliptin and glimepride as add-on therapy in T2DM

volume

11

issue

7

page_start

758

page_end

768

publisher

Journal of Global Pharma Technology

affiliations

Faculty of Pharmacy, Philadelphia University, Jordan; Faculty of Pharmacy, Bilad Al-Rafidain University College, Iraq; Pharmacy Department, Faculty of Pharmacy, Al-Israa University College, Iraq; Consultant of Internal Medicine (Hypertension and Kidney Disease), Princess Basma Teaching Hospital, Jordan

authors_with_affiliations

Bataineh Y.A., Faculty of Pharmacy, Philadelphia University, Jordan; Al-Khames Aga Q.A., Faculty of Pharmacy, Philadelphia University, Jordan; Kurji H.A., Faculty of Pharmacy, Bilad Al-Rafidain University College, Iraq; Hasan M.K., Pharmacy Department, Faculty of Pharmacy, Al-Israa University College, Iraq; Al-Jaidi B.A., Faculty of Pharmacy, Philadelphia University, Jordan; Al-Shorman H.M., Consultant of Internal Medicine (Hypertension and Kidney Disease), Princess Basma Teaching Hospital, Jordan; Faisal R.R., Pharmacy Department, Faculty of Pharmacy, Al-Israa University College, Iraq

cited_by

0

index_keywords

canagliflozin; glimepiride; glucose; hemoglobin A1c; high density lipoprotein; low density lipoprotein; metformin; nitrogen; sitagliptin; triacylglycerol; urea; uric acid; add on therapy; adult; Article; clinical outcome; comparative effectiveness; controlled study; diabetic patient; drug efficacy; drug safety; estimated glomerular filtration rate; fasting; female; glucose blood level; human; kidney function; lipid fingerprinting; major clinical study; male; middle aged; monotherapy; nephrotoxicity; non insulin dependent diabetes mellitus; patient monitoring; randomized controlled trial; treatment duration; urea nitrogen blood level; uric acid blood level